首页 › 基金 › Ikarian Capital, LLC › RAPP
Ikarian Capital, LLC 对 RAPP 的持仓历史
RAPPORT THERAPEUTICS INC · 医疗保健
Ikarian Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 RAPP(RAPPORT THERAPEUTICS INC)166,400 股,市值约 US$5.6M,约占其申报组合的 0.82%,在其申报持仓中市值排名第 33 位。 Ikarian Capital, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Ikarian Capital, LLC 对 RAPP 的持仓演变
Ikarian Capital, LLC 于 Q3 2026 首次披露 RAPP 持仓:166,400 股(约 US$5.6M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 166.40K | $5.59M | 新进 |
关于 RAPP 与 13F 数据
RAPP(RAPPORT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 RAPP,申报仓位最大的包括:TRV GP V, LLC (US$211.0M), ARCH Venture Management, LLC (US$125.3M), Cormorant Asset Management, LP (US$82.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RAPP 的基金
- TRV GP V, LLC 6.28M 股 · $211.03M · Q3 2026
- ARCH Venture Management, LLC 3.73M 股 · $125.29M · Q3 2026
- Cormorant Asset Management, LP 2.46M 股 · $82.57M · Q3 2026
- Sofinnova Investments, Inc. 1.90M 股 · $63.99M · Q3 2026
- JOHNSON & JOHNSON 1.78M 股 · $59.96M · Q3 2026
- BAKER BROS. ADVISORS LP 1.55M 股 · $51.98M · Q3 2026
- TRV GP VI, LLC 969.22K 股 · $32.57M · Q3 2026
- PERCEPTIVE ADVISORS LLC 724.34K 股 · $24.34M · Q3 2026
- Siren, L.L.C. 641.47K 股 · $21.55M · Q3 2026
- Sio Capital Management, LLC 291.23K 股 · $9.79M · Q3 2026
- Casdin 资本 200.00K 股 · $6.72M · Q3 2026
- Artia Global Partners LP 166.51K 股 · $5.59M · Q3 2026
更多关于 Ikarian Capital, LLC
常见问题
How long has Ikarian Capital, LLC held RAPP?
Ikarian Capital, LLC has disclosed RAPP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Ikarian Capital, LLC's current position in RAPP?
As of Q3 2026, Ikarian Capital, LLC holds 166.40K shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $5.59M, representing 0.82% of its reported portfolio and ranking #33.
Has Ikarian Capital, LLC been buying or selling RAPP?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC newly opened its position in RAPP.
Which other funds hold RAPP?
Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.